Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)
Food and Drug Administration
Description
This grant opportunity aims to support innovative studies focused on the natural history of rare diseases that have unmet medical needs. The goal is to fill knowledge gaps, overcome significant obstacles, and make a broad impact on specific or multiple rare diseases, ultimately aiding the development of medical products. The FDA seeks high-quality studies with clear data to achieve these objectives.
The purpose of this notice of funding opportunity (NOFO) is to support efficient and innovative natural history studies that advance medical product development in rare diseases/conditions with unmet needs. Through the support of natural history studies with high quality and interpretable …
Source
Grant ID
FOR-FD-25-017
Funding Source
Food and Drug Administration
Eligibility
The following categories of applicants are invited to apply:
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Awards & Funding
Award Ceiling
$400,000
Funding Amount
Discretionary
Links
Similar opportunities
- Efficient and Innovative Natural History Studies for Rare Diseases
- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01)
- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)
- Notice of Funding Opportunity (NOFO) for Clinical Trials of Orphan Products
- Clinical Trials Addressing Unmet Needs of Rare Neurodegenerative Diseases (R01) Clinical Trials Required